id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-324908-ptlpsnfo	Cao, Huiling	Convalescent plasma: possible therapy for novel coronavirus disease 2019	2020-05-02		.txt	text/plain	2794	182	53	16 Public Health of England and the International Severe Acute Respiratory and Emerging Infection Consortium 17 put forward that convalescent plasma could be a promising specific treatment for serious Middle East respiratory syndrome (MERS), and further evaluation is needed in human clinical trials. Although many studies have reported the efficacy and safety of convalescent plasma infusion in the treatment of various infections, due to the lack of large-scale, randomized, well-designed, and prospective clinical trials, we tend to consider convalescent plasma as an "empirical" therapy. Mortality in the treatment group was significantly lower than in the nontreatment group ( controlled trial reported that patients who received immune plasma and standard care for severe influenza showed a nonsignificant reduction in the mortality rate. In conclusion, the transfusion of up to 500 mL of convalescent plasma with unknown levels of neutralizing antibodies in 84 patients with confirmed Ebola virus infection was not associated with a significant improvement in survival.	./cache/cord-324908-ptlpsnfo.txt	./txt/cord-324908-ptlpsnfo.txt